SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 220 filers reported holding SAGE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $450 | -99.9% | 10,721 | -20.9% | 0.04% | -35.7% |
| Q3 2022 | $531,000 | -12.4% | 13,557 | -27.7% | 0.07% | -23.1% |
| Q2 2022 | $606,000 | -45.3% | 18,750 | -28.0% | 0.09% | -34.5% |
| Q4 2021 | $1,108,000 | +198.7% | 26,035 | +211.0% | 0.14% | +265.8% |
| Q3 2021 | $371,000 | -62.4% | 8,371 | -51.8% | 0.04% | -65.8% |
| Q2 2021 | $987,000 | +75.9% | 17,381 | +167.9% | 0.11% | +20.7% |
| Q4 2020 | $561,000 | +93.4% | 6,487 | +36.7% | 0.09% | +91.7% |
| Q3 2020 | $290,000 | -52.8% | 4,744 | -77.8% | 0.05% | -68.8% |
| Q1 2020 | $614,000 | +38.0% | 21,374 | +246.6% | 0.15% | +196.2% |
| Q4 2019 | $445,000 | +8.8% | 6,167 | +10.1% | 0.05% | +225.0% |
| Q2 2015 | $409,000 | – | 5,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |